Images List Premium Download Classic

Specificity

Specificity-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
System and method for providing access to media content associated with events, using a digital ...
Spotify Ab
July 05, 2018 - N°20180192240

In accordance with an embodiment, described herein is a system and method for providing access to media content associated with events, using a digital media content environment. A media application enables display of a memory event timeline, including a plurality of memory events, to provide an improved presentation of media consumption by a user that resembles a person's memory or ...
Method for proposal of compound analog structures using accurate product ion spectra
Dh Technologies Development Pte. Ltd.
July 05, 2018 - N°20180190480

A metabolized product ion spectrum is produced for a metabolized version of a known compound using tandem mass spectrometry. Metabolized structures are inferred from the metabolized product ion spectrum.
Continuous malicious software identification through responsive machine learning
Barkly Protects, Inc.
July 05, 2018 - N°20180189484

A security system and method secures and responds to security threats in a computer having a cpu, a kernel/os, and software applications. A low-level data collector intercepts a selection of first tier calls between the cpu and kernel/os, and stores associated first tier call ids.
Specificity Patent Pack
Download 262+ patent application PDFs
Specificity Patent Applications
Download 262+ Specificity-related PDFs
For professional research & prior art discovery
inventor
  • 262+ full patent PDF documents of Specificity-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Cardiomyocyte-specific biological markers and uses thereof
The Medical College Of Wisconsin, Inc.
July 05, 2018 - N°20180188268

The present invention is directed to particular monoclonal antibodies and fragments thereof that find use in the detection and isolation of in vitro differentiated cardiomyocytes. In particular, the present invention relates to lsmem2 biomarkers, including monoclonal antibodies having specificity for cell surface protein lsmem2 and to methods of using such biomarkers for diagnosis of cardiovascular injury..
Salivary biomarkers for gastric cancer detection
The Regents Of The University Of California
July 05, 2018 - N°20180188256

Disclosed herein are biomarkers related to gastric cancer. The presently identified salivary biomarkers create the basis for a gastric cancer detection bioassay with sensitivity and specificity.
Method for the in situ formation of bifunctional immunological complexes
Stemcell Technologies Inc.
July 05, 2018 - N°20180188245

An improved method for the preparation of tetrameric antibody complexes directly on the surface of target entities in a sample is described. In particular, this method involves linking, in the sample, a first target entity with a second target entity in a sample using antibodies with specificity for the first and second target entities..
Specificity Patent Pack
Download 262+ patent application PDFs
Specificity Patent Applications
Download 262+ Specificity-related PDFs
For professional research & prior art discovery
inventor
  • 262+ full patent PDF documents of Specificity-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Rna-directed dna cleavage by the cas9-crrna complex
Vilnius University
July 05, 2018 - N°20180187195

Isolation or in vitro assembly of the cas9-crrna complex of the streptococcus thermophilus crispr3/cas system and use for cleavage of dna bearing a nucleotide sequence complementary to the crrna and a proto-spacer adjacent motif. Methods for site-specific modification of a target dna molecule in vitro or in vivo using an rna-guided dna endonuclease comprising rna sequences and at ...
Methods and compositions for enhancing the efficacy and specificity of single and double blunt-ended sirna
University Of Massachusetts
July 05, 2018 - N°20180187194

The present invention provides methods of enhancing the efficacy and specificity of rnai using single or double blunt-ended sirna. The invention also provides single and double-blunt ended sirna compositions, vectors, and transgenes containing the same for mediating silencing of a target gene.
Pepmixes to generate multiviral ctls with broad specificity
Baylor College Of Medicine
July 05, 2018 - N°20180187152

The present invention concerns methods of generating ctls that are able to target at least one antigen from two or more viruses. The method includes exposing mixtures of peptides for different antigens to the same plurality of pbmcs and, at least in certain aspects, expanding the cells in the presence of il4 and il7..
Fzd7 specific antibodies and vaccines to treat cancer and control stem cell function
The Regents Of The University Of California
July 05, 2018 - N°20180186885

The present invention is directed to antibodies and fragments thereof having binding specificity for fzd7, which preferably do not substantially interact with (bind to) other fzd family members, and methods of making said anti-fzd7 antibodies and binding fragments thereof. Another embodiment relates to antibodies and binding fragments comprising sequences of vh, vl and/or cdr polypeptides described herein.
Human antibodies to pd-l1
Regeneron Pharmaceuticals, Inc.
July 05, 2018 - N°20180186883

The present invention provides antibodies that bind to the t-cell co-inhibitor ligand programmed death-ligand1 (pd-l1) protein, and methods of use. In various embodiments of the invention, the antibodies are fully human antibodies that bind to pd-l1.
Antibodies to il-6 and use thereof
Alderbio Holdings Llc
July 05, 2018 - N°20180186874

The present invention is directed to antibodies and fragments thereof and humanized versions thereof having binding specificity for il-6. Another embodiment of this invention relates to the antibodies described herein, and binding fragments thereof, comprising the sequences of the vh, vl and cdr polypeptides described herein, and the polynucleotides encoding them.
Human antibodies to pd-1
Regeneron Pharmaceuticals, Inc.
July 05, 2018 - N°20180185668

The present invention provides antibodies that bind to the t-cell co-inhibitor programmed death-1 (pd-1) protein, and methods of use. In various embodiments of the invention, the antibodies are fully human antibodies that bind to pd-1.
Specificity Patent Pack
Download 262+ patent application PDFs
Specificity Patent Applications
Download 262+ Specificity-related PDFs
For professional research & prior art discovery
inventor
  • 262+ full patent PDF documents of Specificity-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Compositions and methods for altering tissue specificity and improving aav9-mediated gene transfer
The Trustees Of The University Of Pennsylvania
July 05, 2018 - N°20180185405

A method of altering the targeting and/or cellular uptake efficiency of an adeno-associated virus (aav) viral vector having a capsid containing an aav9 cell surface binding domain is described. The method involves modifying a clade f cell surface receptor which comprises a glycan having a terminal sialic acid residue and a penultimate β-galactose residue.
Method, an arrangement and a computer program product for analysing a biological or medical sample
Medisapiens Oy
June 28, 2018 - N°20180181705

An aspect of the present invention is a computer executable method for characterizing, e.g. For diagnostic purposes, utilizing a reference database, a query sample based on the measurements of biological components.
Highly automated application of digital finish material to 3d data
Dassault Systemes 3dexcite Corp.
June 28, 2018 - N°20180181109

Methods and systems display a computer-aided design (cad) model with finish material specificity. An example embodiment begins by defining a cad model in memory where the cad model represents a real world physical object and the cad model comprises a plurality of parts.
T cell receptor like antibodies having fine specificity
Adicet Bio Inc.
June 28, 2018 - N°20180179283

An antibody capable of binding, with a human major histocompatibility complex (mhc)-restricted specificity, a mhc being complexed with an hla-restricted peptide antigen is provided. The antibody having a binding specificity dictated by at least 4 amino acid residues in said hla-restricted peptide such that at least 70% reduction in binding of said antibody to said complex is observed when each of ...
Anti-ccl2 antibodies for treatment of scleroderma
Shire Human Genetic Therapies, Inc.
June 28, 2018 - N°20180179275

The present invention provides, among other things, improved anti-ccl2 antibodies characterized with high affinity, potency, tissue selectivity and/or epitope specificity, and uses thereof, in particular, for treatment of scleroderma and related fibrotic and/or inflammatory diseases, disorders and conditions. In some embodiments, the present invention provides methods and compositions for treatment of scleroderma and related fibrotic and/or inflammatory ...
Redirected cells with mhc chimeric receptors and methods of use in immunotherapy
Joslin Diabetes Center, Inc.
June 28, 2018 - N°20180179260

Chimeric receptors featuring major histocompatibility molecules grafted onto t cell receptor molecules and surrogate co-receptors featuring cell surface receptor ligands fused with signaling molecule domains. The chimeric receptors can be used to redirect cells, altering their specificity.
Biomarkers and methods for predicting preterm birth
Sera Prognostics, Inc.
June 21, 2018 - N°20180172696

The disclosure provides biomarker panels, methods and kits for determining the probability for preterm birth in a pregnant female. The present disclosure is based, in part, on the discovery that certain proteins and peptides in biological samples obtained from a pregnant female are differentially expressed in pregnant females that have an increased risk of developing in the future or presently ...
Affinity entities comprising a tcr-like antibody binding domain with high affinity and fine specificity and ...
Adicet Bio Inc.
June 21, 2018 - N°20180171024

Affinity binding entities having tcrl binding domain and methods of their use are provided. More specifically these compositions bind hla-a2/wt1+, hla-a2/mage-a4, hla-a2/mage-a9, hla-a2/pap or hla-a2/tyrd+ cells and as such can be used in diagnostics and therapy..
Loading